Published in Blood Weekly, January 15th, 2009
"The experiments were completed within a laboratory setting. Participant: The first recipient of targeted muscle reinnervation: a bilateral shoulder disarticulation-level amputee. Two years after surgery, the subject was fitted with a 6 degree of freedom (DOF) prosthesis...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.